Heart Disease News and Research

Latest Heart Disease News and Research

BSO drug mimics anti-obesity effects of difficult sulfur amino acid restricted diet

A new research paper was published in Aging (Aging-US) Volume 17, Issue 4, on April 7, 2025, titled "Pharmacological recapitulation of the lean phenotype induced by the lifespan-extending sulfur amino acid-restricted diet."

13 May 2025

Pentoxifylline offers no survival benefit for severe alcohol-associated hepatitis

Severe alcohol-associated hepatitis (sAH) remains a highly lethal condition with limited therapeutic options. Characterized by rapid liver decompensation, sAH is often accompanied by acute kidney injury (AKI), a complication that substantially worsens prognosis.

13 May 2025

Flavan-3-ols in tea and chocolate can lower blood pressure

We might have another reason to enjoy our daily cup of tea or small piece of dark chocolate, as a new study from the University of Surrey has found that naturally occurring compounds called flavan-3-ols - found in cocoa, tea, apples and grapes - may improve blood pressure and the health of our blood vessels.

13 May 2025

Multiple health conditions linked to higher depression risk

People with multiple long-term physical health conditions are at a significantly greater risk of developing depression, a study shows.

13 May 2025

Early cardiovascular benefits of semaglutide seen within months in SELECT trial

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or obesity who have pre-existing cardiovascular disease but not diabetes, according to a secondary analysis of the landmark Semaglutide and Cardiovascular Outcomes (SELECT) trial from the same international author team being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain.

12 May 2025

Study shows cardiovascular benefits of GLP-1RAs in patients following bariatric surgery

Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with obesity and diabetes following bariatric surgery who did not achieve sufficient weight loss and diabetes control, according to new research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain.

12 May 2025

Estrogen-related receptors could be a key to repairing energy metabolism and muscle fatigue

A new Salk Institute study suggests estrogen-related receptors could be a key to repairing energy metabolism and muscle fatigue.

12 May 2025

Study links gum disease symptoms to higher risk of multiple chronic conditions

A major new study presented at EuroPerio11, the world's leading congress in periodontology and implant dentistry by the EFP, has found that people with signs of gum disease are more likely to suffer from multiple chronic health conditions, a state known as multimorbidity.

12 May 2025

Tirzepatide outperforms semaglutide for weight loss in people without diabetes

A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in adults with obesity but without diabetes. Over 72 weeks, tirzepatide helped more participants reach key weight loss milestones, with manageable side effects and strong metabolic benefits.

12 May 2025

Intermittent fasting may dampen inflammatory responses in the gums

New research presented today at EuroPerio11, the world's leading congress in periodontology and implant dentistry by the European Federation of Periodontology (EFP), suggests that intermittent fasting could help reduce inflammation in the gums and improve certain health markers, even when oral hygiene is temporarily neglected.

12 May 2025

Hearing aids may help older adults combat social isolation

Providing hearing aids and advice on their use may preserve social connections that often wane as we age, a new study shows.

12 May 2025

Tirzepatide outperforms semaglutide in weight loss clinical trial

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the injectable drugs.

12 May 2025

Millions of women may be unaware of their risk for cardiovascular-kidney-metabolic disease

Millions of women may be unknowingly living with risk factors for heart, kidney and metabolic disease – interconnected conditions that together drive risk for cardiovascular disease, the leading cause of death among women, according to experts with the American Heart Association, a global force changing the future of health for all.

12 May 2025

Adverse waist-to-height ratio trajectories during childhood linked to early cardiometabolic risk

New research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) reveals that adverse waist-to-height ratio trajectories (a marker for central obesity) during childhood may increase cardiometabolic and cardiovascular risk at 10 years old.

11 May 2025

Scientists link specific gene variants to post-vaccine myocarditis and pericarditis

A genome-wide association study in Sweden identified rare genetic variants near the SCAF11 and LRRC4C genes that may be linked to heart inflammation following COVID-19 mRNA vaccination. The findings shed light on potential biological pathways driving vaccine-associated myocarditis and pericarditis, particularly among younger individuals.

11 May 2025

Sumeet Chugh named vice dean and chief artificial intelligence health research officer at Cedars-Sinai

Sumeet Chugh, MD, whose research into sudden cardiac arrest has led to novel methods of predicting the usually fatal condition, has been promoted to vice dean and chief artificial intelligence health research officer at Cedars-Sinai.

11 May 2025

Infertility in women linked to higher risk of heart disease

Women who experience infertility are more likely to develop heart and blood vessel conditions later in life, with younger women and those who undergo fertility treatments at a greater risk.

11 May 2025

Maternal testosterone levels shape boys' activity and girls' strength by age 7

Boys born to mothers with PCOS or high third-trimester testosterone levels are less physically active at age 7, particularly on weekends. Girls exposed to high prenatal testosterone show reduced muscle strength but not lower activity levels.

10 May 2025

Gum disease bacterium linked to increased risk of atrial fibrillation

Tempted to skip the floss? Your heart might thank you if you don't. A new study from Hiroshima University (HU) finds that the gum disease bacterium Porphyromonas gingivalis (P. gingivalis) can slip into the bloodstream and infiltrate the heart.

10 May 2025

New QR4 model identifies hidden risk factors in cardiovascular disease

Collaborative research, led from the University of Oxford and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of cardiovascular diseases, like heart disease and stroke, particularly identifying high-risk patients that current prediction tools miss.

9 May 2025

Previous
1
...
65
66
67
68
69
70
71
...
2983
Next

Heart Disease News and Research

Latest Heart Disease News and Research

BSO drug mimics anti-obesity effects of difficult sulfur amino acid restricted diet

Pentoxifylline offers no survival benefit for severe alcohol-associated hepatitis

Flavan-3-ols in tea and chocolate can lower blood pressure

Multiple health conditions linked to higher depression risk

Early cardiovascular benefits of semaglutide seen within months in SELECT trial

Study shows cardiovascular benefits of GLP-1RAs in patients following bariatric surgery

Estrogen-related receptors could be a key to repairing energy metabolism and muscle fatigue

Study links gum disease symptoms to higher risk of multiple chronic conditions

Tirzepatide outperforms semaglutide for weight loss in people without diabetes

Intermittent fasting may dampen inflammatory responses in the gums

Hearing aids may help older adults combat social isolation

Tirzepatide outperforms semaglutide in weight loss clinical trial

Millions of women may be unaware of their risk for cardiovascular-kidney-metabolic disease

Adverse waist-to-height ratio trajectories during childhood linked to early cardiometabolic risk

Scientists link specific gene variants to post-vaccine myocarditis and pericarditis

Sumeet Chugh named vice dean and chief artificial intelligence health research officer at Cedars-Sinai

Infertility in women linked to higher risk of heart disease

Maternal testosterone levels shape boys' activity and girls' strength by age 7

Gum disease bacterium linked to increased risk of atrial fibrillation

New QR4 model identifies hidden risk factors in cardiovascular disease

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Heart Disease News and Research

Latest Heart Disease News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in